Lab
Care Bio Clinical Corp
Care Bio Clinical Corp was paid $564K by Medicaid between Jan 2018 and Feb 2024, across 50 billing codes. Its largest line is 87491, Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe — 31% of everything it billed.
33Billing provider infoCARE BIO CLINICAL CORP
ENCINO, CA 91436
ENCINO, CA 91436
33aNPI1588713531assigned 01/09/2007
33bProvider typeClinical Medical Laboratory
28Total paid$564K
24GClaims36,550
24DCodes billed50
24AFirst – last monthJan 2018 – Feb 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in California
Rank by total paid#224 of 561
Median peer was paid$222K
This provider vs. median2.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,603 | $298K | |
| 2019 | 7,035 | $102K | |
| 2020 | 1,788 | $27K | |
| 2021 | 4,911 | $91K | |
| 2022 | 532 | $14K | |
| 2023 | 1,311 | $32K | |
| 2024incomplete | 370 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 31% | 5,752 | 5,513 | $174K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 31% | 5,760 | 5,521 | $174K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 15% | 4,349 | 4,107 | $86K |
| 86592 | 5.0% | 7,562 | 7,301 | $28K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.1% | 541 | 150 | $23K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.7% | 223 | 93 | $15K |
| 86703 | 1.4% | 693 | 693 | $8K | |
| 86769 | 1.3% | 135 | 101 | $7K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.2% | 330 | 142 | $7K |
| 84702 | <1% | 401 | 394 | $5K | |
| 86762 | <1% | 403 | 403 | $5K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 888 | 834 | $5K |
38 more codes
| 87340 | <1% | 419 | $3K | |
| 80061 | Lipid panel | <1% | 468 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 417 | $3K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 412 | $3K |
| 87081 | <1% | 331 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 175 | $2K |
| 84481 | <1% | 207 | $1K | |
| 80053 | Comprehensive metabolic panel | <1% | 272 | $1K |
| 83735 | <1% | 384 | $1K | |
| 83615 | <1% | 397 | $1K | |
| 87088 | <1% | 167 | $912.12 | |
| 84439 | <1% | 273 | $859.39 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 58 | $741.23 |
| 83540 | <1% | 314 | $723.62 | |
| 81000 | <1% | 318 | $662.30 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 182 | $494.51 |
| 82947 | <1% | 464 | $409.17 | |
| 84550 | <1% | 331 | $357.65 | |
| 85651 | <1% | 254 | $321.84 | |
| 82977 | <1% | 392 | $255.27 | |
| 84295 | <1% | 315 | $158.49 | |
| 81025 | <1% | 43 | $130.44 | |
| 84100 | <1% | 345 | $106.83 | |
| 87184 | <1% | 27 | $102.87 | |
| 82040 | <1% | 138 | $87.83 | |
| 82247 | <1% | 138 | $85.97 | |
| 82565 | <1% | 310 | $83.14 | |
| 82310 | <1% | 309 | $66.95 | |
| 82435 | <1% | 309 | $55.61 | |
| 84520 | <1% | 318 | $43.43 | |
| 84132 | <1% | 314 | $30.64 | |
| 84155 | <1% | 140 | $18.71 | |
| 84450 | <1% | 162 | $16.98 | |
| 84460 | <1% | 164 | $8.71 | |
| 84075 | <1% | 140 | $7.12 | |
| 81002 | <1% | 57 | $1.94 | |
| 86141 | 0% | 36 | $0.00 | |
| 83550 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHOFFMAN, WOLF (CREDENTIALING)
| Provider | Location | Paid |
|---|---|---|
| Unitec Laboratories INC | New York, NY | $486K |
| Thomas G Rosano PHD LLC | Albany, NY | $331.14 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.